• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Anavex Life Sciences Corp

+ Add to Watchlist

AVXL:US

0.2401 USD 0.0099 3.96%

As of 11:00:20 ET on 09/02/2014.

Snapshot for Anavex Life Sciences Corp (AVXL)

Open: 0.2500 Day's Range: 0.2400 - 0.2600 Volume: 18,300
Previous Close: 0.2500 52wk Range: 0.2298 - 0.6900 1-Yr Rtn: -60.70%

Stock Chart for AVXL

No chart data available.
  • AVXL:US 0.2430
  • 1D
  • 1M
  • 1Y
0.2500
Interactive AVXL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AVXL

Current P/E Ratio (ttm) -
Estimated P/E(09/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.1200
Est. EPS (USD) (09/2014) -0.0400
Est. PEG Ratio -
Market Cap (M USD) 9.57
Shares Outstanding (M) 38.26
30 Day Average Volume 240,033
Price/Book (mrq) 1.0925
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 12/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AVXL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AVXL

Anavex Life Sciences Corporation is a biopharmaceutical company engaged in the discovery and development of new drugs for the treatment of neurological diseases and cancer.

Christopher U MisslingPres/CEO/CFO/Treasurer/SecyAlexandre VamvakidesChief Scientific Officer
More Company Profile & Key Executives for AVXL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil